Fibromyalgia Syndrome (FMS) is a condition that causes widespread pain, sleep problems, fatigue, and often emotional and mental distress. People with FMS may be more sensitive to pain. FMS affects about 4 million US adults who suffer from this long-misunderstood condition. Little relief is offered with lasting results and the medications prescribed have unpleasant side effects and poor outcomes. There is light at the end of the tunnel for FMS sufferers. Through a photoceutical approach to care our Platinum Sponsor, Multi Radiance Medical, is announcing their new patent pending FibroLux therapeutic laser device. The FibroLux represents a breakthrough in pain management options, offering patients a non-pharmacological, non-invasive, and side effect-free treatment for FMS that is now cleared by the FDA and is indicated for adjunctive use in the temporary relief of pain associated with fibromyalgia. Join Dr. Christopher Carraway, Professor Timothy Demchak, ATC, PhD, Indiana State University, and Douglas Johnson, Senior Vice President of Clinical Scientific Affairs with Multi Radiance Medical as they discuss this exciting modality and treatment.